- This event has passed.
COVID19: CRISIS – LESSONS – CRISIS
June 18, 2020 @ 11:00 am - 12:00 pm
Philadelphia-Israel Chamber of Commerce (PICC) is excited to present “COVID19: Crisis-Lessons-Crisis”, a live Zoom event with Dov Moran, Managing Director of Grove Ventures (click for bio), and one of Israel’s best known entrepreneurs, inventor of the memory stick, and investor. Israel’s early and comprehensive approach to combating the corona outbreak not only limited its spread, but also positioned Israel as a leading center for innovation to fight the COVID19 crisis. Dov Moran advised the Israeli government on reopening the economy. Dov is also an expert on digital transformation technologies, and we are in the midst of a technological revolution. Join us to hear his insights, lessons learned, and how we prepare for the next pandemic wave.
- Vered Nohi, Executive Director, Philadelphia-Israel Chamber of Commerce and Representative in PA, DE and SNJ for BIRD Foundation
- Inon Elroy, Economic Minister to North America, Israel Economic Mission in NYC (click for bio)
Keynote speaker: Dov Moran, Managing Partner, Grove Ventures
Moderator: Shouvanik Chatterjee, Global Head of Corporate Development and M&A, Indegene, and a Board Member of the Philadelphia-Israel Chamber of Commerce (click for bio)
- Dov Moran, Managing Partner, Grove Ventures
- Jeffrey Berkowitz, CEO and Director, Real Endpoints (click for bio)
We Thank our Promoting partners:
Dov Moran is one of Israel’s most prominent hi-tech leaders, entrepreneurs, and investors. He was recently appointed a special advisor to Israel’s Government on reopening the Israeli business market during COVID19. He is best known as a pioneer of several flash memory technologies, most notably as the inventor of the USB flash drive. In 2006, the company behind the USB flash drive (DiskOnKey), M-Systems, led by Mr. Moran, was acquired by SanDisk Corp for $1.6B.
After the acquisition of M-Systems, Mr. Moran founded a few more technological companies, among them, are Comigo (in which he still serves as a chairman), GlucoMe (currently serves as a board member) and Modu (served as chairman and CEO of the company). During his time at Modu, he was also the chairman of Tower Semiconductor. During his career, Mr. Moran also served in other board positions. Notable companies are Consumer Physics, Geneformics, Rapid API, and Kidoz.
In the course of his entrepreneurial work, Moran has filed more than 40 patents.
Mr. Moran is currently the founder and managing partner of Grove Ventures, an early-stage fund focused on technologies and solutions in the areas of IoT, cloud, and big data.
Inon Elroy was appointed Economic Minister to North America in August 2016. Mr. Elroy has more than twenty years of experience representing the Ministry of Economy and Industry in a wide range of executive positions both in Israel and overseas.
As Vice Director General of the Israel Ministry of Economy and Industry from 2012-2016, Mr. Elroy was tasked with overseeing industrial policy (promoting domestic production and innovation), trade regulations (liberalization of imports, anti dumping, and standardization), and regional economic planning. In addition, he supervised the Ministry’s digital strategy, and initiated policies to foster innovation synergies between the public and private sectors. During his tenure at the Ministry, Mr. Elroy was also involved in several inter-ministerial task forces aimed at reducing the cost of living in Israel.
Mr. Elroy served as the Economic and Commercial Counselor in France (2001-2005) and Germany (2009-2011). Earlier in his career, he was an advisor to several ministers of Economy and Trade.
For the past several years, Mr. Elroy has been a board member of the research committee of the Office of the Chief Scientist, which approves industrial R&D projects. He was also Alternate Director for the bi-national R&D funds BIRD, SIIRD, and KORIL. Additionally, he served on the boards of the Israel Wine Institute and the Israel Consumer Council.
Mr. Elroy holds an MBA from the University of Haifa and a BA degree in Political Science and Geography from the Hebrew University in Jerusalem.
Shouvanik is an entrepreneurial leader with more than 20 years of Executive management and leadership experience in Healthcare and Financial services. He has successfully led companies through their stages of growth & progression by leading globally diverse teams, successful mergers& divestitures and Capital raise. He is also well versed in incubating new business units for mature corporations.
Shouvanik is currently focused on emerging application of analytics, big data, and digital transformation in Lifesciences and healthcare industries. He heads the Corporate development& strategic initiative function of Indegene inc, a leading provider of advanced digital and analytics-based solutions to the life science industry. He was previously the Chief operating officer of Indegene Encima. He successfully led the sale of “The Encima group’ to Indegene Inc in late 2016 and integrated both companies.
Prior to the sale Shouvanik was a Partner and COO of The Encima group, an analytics, data solutions and insights provider to Big Pharma and healthcare companies. The Encima group was an Inc 500 fastest growing companies for 4 years. As the COO he was able to optimize operations, diversify portfolio of solutions, switch the business model to create scale.
His career included: CEO of Digitech Communications (now BIBI money); President of ARMI (Aegis receivable management) and SVP in the parent company, Aegis (An ESSAR Group Company) , which has since been sold to Teleperformance SA.
Shouvanik has an undergraduate degree in finance & economics and an MBA from Mumbai University. He is a sports enthusiast and a cinema buff. He resides in Princeton, NJ.
Jeff Berkowitz’s perspective has been shaped by a career spanning most key verticals in healthcare with executive committee and other senior roles at UnitedHealth Group, Walgreens Boots Alliance and Merck. Jeff, a lawyer by training, is a recognized expert in market access and reimbursement for pharmaceuticals and serves on the board of directors of a number of publicly traded pharmaceutical companies including Lundbeck A/S, Esperion Therapeutics, Zealand Pharmaceuticals and Infinity Pharmaceuticals.
Jeff is currently the CEO of Real Endpoints, a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value based arrangements, patient services and access support for manufacturers and payers.